GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » EV-to-FCF

ACME Laboratories (DHA:ACMELAB) EV-to-FCF : -9.35 (As of May. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ACME Laboratories's Enterprise Value is BDT35,582 Mil. ACME Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was BDT-3,805 Mil. Therefore, ACME Laboratories's EV-to-FCF for today is -9.35.

The historical rank and industry rank for ACME Laboratories's EV-to-FCF or its related term are showing as below:

DHA:ACMELAB' s EV-to-FCF Range Over the Past 10 Years
Min: -161.63   Med: -16.06   Max: 187.94
Current: -9.35

During the past 8 years, the highest EV-to-FCF of ACME Laboratories was 187.94. The lowest was -161.63. And the median was -16.06.

DHA:ACMELAB's EV-to-FCF is ranked worse than
100% of 524 companies
in the Drug Manufacturers industry
Industry Median: 25.35 vs DHA:ACMELAB: -9.35

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), ACME Laboratories's stock price is BDT67.10. ACME Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was BDT8.765. Therefore, ACME Laboratories's PE Ratio for today is 7.66.


ACME Laboratories EV-to-FCF Historical Data

The historical data trend for ACME Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories EV-to-FCF Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Get a 7-Day Free Trial -15.19 -28.47 31.78 -54.45 -9.38

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.48 -10.75 -9.38 -9.87 -20.86

Competitive Comparison of ACME Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's EV-to-FCF falls into.



ACME Laboratories EV-to-FCF Calculation

ACME Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=35581.525/-3804.921
=-9.35

ACME Laboratories's current Enterprise Value is BDT35,582 Mil.
ACME Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-3,805 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACME Laboratories  (DHA:ACMELAB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ACME Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=67.10/8.765
=7.66

ACME Laboratories's share price for today is BDT67.10.
ACME Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT8.765.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ACME Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines